Delivery of recombinant coagulation factor VIIa concentrate to regional blood donation centers
Delivery of recombinant coagulation factor VIIa concentrate: for ensuring continuous treatment of patients with hemophilia A and B (complicated by inhibitor) and acquired/congenital hemophilia A, with Rp or Rpz availability category, to Regional Blood Donation and Blood Treatment Centers (RCKiK) or other entities specified by the National Blood Center (NCK); total quantity 15,000 mg; delivery includes an administration set; the purchase quantity may be reduced by up to 20%; part of the "National Program for the Treatment of Patients with Hemophilia and Related Hemorrhagic Diatheses for 2024-2028"; the contracting authority reserves the right to cancel the procedure or withdraw from the contract without compensation; the distribution list of recipients and quantities will be provided by the NCK after contract signing.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33621000, Medicinal products for the blood and blood-forming organs.
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
10 days remaining(LOT-0001)
Published